SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Moderna, Inc. engages in the development of transformative medicines based on messenger ribonucleic acid. The firm's product pipeline includes the following modalities: prophylactic vaccines, cancer vaccines, intratumoral immuno-oncology, localized regenerative therapeutics, systemic secreted therapeutics, inhaled pulmonary therapeutics and systemic intracellular therapeutics. It operates through the following geographical segments: United States, Europe, and Rest of World. The company was founded by Noubar B. Afeyan, Robert S. Langer, Jr., Derrick J. Rossi, and Kenneth R. Chien in 2010 and is headquartered in Cambridge, MA.

Moderna Inc

Modernas rally is tied to the Phase 3 melanoma vaccine trial meeting its main endpoints and anticipation of the full data presentation, alongside CEO comments emphasizing the companys broader mRNA pipeline. Bullish traders cite the cancer-treatment potential and possible short covering, while skeptics argue the surge prices in unproven commercial prospects and leaves the stock overvalued.

BlackBerry Ltd. engages in the provision of intelligent security software and services. It operates through the following segments: QNX, Secure Communications, and Licensing. The QNX segment includes development of safe and reliable software for embedded systems across technology-driven industries. The Secure Communications segment delivers operational resiliency with a government-grade portfolio of secure, certified solutions for mobile fortification, critical communications and crisis management. The Licensing segment focuses on management and monetization of the firm's global patent portfolio. The company was founded by Michael Lazaridis, James Laurence Balsillie, and Douglas E. Fregin on March 7, 1984 and is headquartered in Waterloo, Canada.

BlackBerry Ltd

BlackBerrys quarterly results beat expectations and lifted its full-year revenue outlook, with record QNX growth fueling optimism; traders also focused on a reported Uber QNX design win and the Coretura/Alloy Kore contract. The reaction is divided: bulls see momentum in automotive software and new design wins, while skeptics point to softer near-term guidance and question why the shares did not rise more.

Infleqtion, Inc. engages in delivering neutral atom solutions for quantum computing, networking, sensing, and security. Its products are categorized into computing, sensing, and cores. The company was founded on February 7, 2007, and is headquartered in Louisville, CO.

Infleqtion Inc. - Ordinary Shares - Class A

Infleqtion Inc.

Infleqtions reported achievement of 30 entangled logical qubits on its Sqale quantum computer, using 80 physical qubits, is the dominant catalyst, with traders viewing it as progress toward fault-tolerant, commercial quantum computing. The milestone has drawn bullish attention, though some question how much it changes the competitive picture and note that the share-price reaction has been restrained amid broader market pressure.

Costco Wholesale Corp. engages in the provision of operation of membership warehouses through wholly owned subsidiaries. It operates through the following geographical segments: United States, Canada, and Other International Operations. The company was founded by James D. Sinegal and Jeffrey H. Brotman in 1983 and is headquartered in Issaquah, WA.

Costco Wholesale Corp

Costcos quarterly results beat expectations, but the stock barely moved and faced selling as traders weighed steady underlying comparable-sales growth against a one-time tariff-refund boost to earnings and a high valuation. Bulls pointed to resilient demand, while skeptics questioned whether growth and earnings can justify the premium.

Akamai Technologies, Inc. is the cybersecurity and cloud computing company that powers and protects business online. The market security solutions, superior threat intelligence, and global operations team provide defense in depth to safeguard enterprise data and applications everywhere. The firm full-stack cloud computing solutions deliver performance and affordability on the world’s most distributed platform. The global enterprises trust Akamai to provide the industry reliability, scale, and expertise they need to grow their business with confidence. The company was founded by Frank T. Leighton, Jonathan Seelig, Randall S. Kaplan, and Daniel M. Lewin on August 20, 1998 and is headquartered in Cambridge, MA.

Akamai Technologies Inc

Akamais multiyear Anthropic cloud-infrastructure agreement is driving attention, with traders viewing it as a major validation of its AI-cloud opportunity. The bullish reaction is tempered by concerns about the capital spending required and potential share dilution from warrants, alongside profit-taking after the initial surge.

Nektar Therapeutics is a biotechnology company, which engages in the discovery and development of novel therapies which selectively modulate the immune system to treat autoimmune disorders. It also focuses on immunology and unparalleled expertise in polymer chemistry to create one-of-a-kind, highly-selective medicines with optimal therapeutic benefit. The company was founded in 1990 and is headquartered in San Francisco, CA.

Nektar Therapeutics

Nektars breach-of-contract case with Eli Lilly over Rezpeg is dominating discussion, with traders reacting to reports of a roughly $90 million award while debating whether the result is a meaningful win or far below hoped-for damages. Conflicting claims about the verdict and uncertainty over its details are fueling volatile reactions and speculation about the litigations value to NKTR.

The Ondo Foundation was founded in 2022 as an independently governed and nonprofit Cayman Islands Foundation Company with no beneficial owners. The Ondo Foundation assisted in the launch of the Ondo DAO, which deployed and currently governs Flux Finance, the first lending protocol supporting tokenized securities as collateral.  ONDO token holders are entrusted with shaping the future of the Ondo DAO so that it continues to pursue its mission to democratize access to institutional-grade finance. The Ondo DAO gives ONDO holders specific rights pertaining to Flux Finance, which is currently governed by the Ondo DAO.

Ondo

Ondos tokenization push, including BlackRock-powered onchain portfolios and DTCC-related developments, is drawing attention amid a sharp ONDO rally. Bulls point to institutional adoption and the RWA theme, while skeptics cite profit-taking and the tokens limited direct value accrual without a fee-sharing mechanism.

Tempus AI, Inc. is a healthcare technology company, which engages in bringing artificial intelligence and machine learning to healthcare. It focuses on building platforms for oncology, neuropsychiatry, cardiology, infectious disease, and radiology. The company was founded by Eric Paul Lefkofsky in August 2015 and is headquartered in Chicago, IL.

Tempus AI Inc. - Ordinary Shares - Class A

Tempus AI Inc

Tempus shares are drawing attention after a sharp rally tied in community discussion to a more favorable reimbursement outlook for its cancer diagnostics and analyst optimism about growth. Traders also cite heavy short interest and bullish options flow as potential fuel, while others question the valuation and point to insider selling as a risk.

Eli Lilly & Co. engages in the discovery, development, manufacture, and sale of pharmaceutical products. The firm's products include diabetes, oncology, immunology, neuroscience, and other products and therapies. The company was founded by Eli Lilly on May 10, 1876 and is headquartered in Indianapolis, IN.

Lilly(Eli) & Co

FDA clearance of Lillys once-weekly basal insulin Onswik is driving attention, with traders highlighting the potential to reduce injection frequency for adults with type 2 diabetes. The news is viewed positively and puts Lilly into direct competition with Novos weekly insulin, Awiqli.

First Solar, Inc. is a solar technology company, which engages in the provision of solar modules. It is involved in the design, manufacture, and sale of cadmium tellurid (CdTe) solar modules, which convert sunlight into electricity. The company was founded by Michael J. Ahearn in 1999 and is headquartered in Phoenix, AZ.

First Solar Inc

First Solars steep selloff and fresh 52-week low are being tied to analyst downgrades and concerns about limited visibility into 2026 bookings, amid broader solar-sector pressure from higher rates and trade-policy uncertainty. Traders are divided between calling the decline an oversold buying opportunity and expecting further losses; speculation about China-related policy news and short selling remains unconfirmed.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Wall Street Analysts See a 103.26% Upside in Green Thumb Industries Inc. (GTBIF): Can the Stock Really Move This High?

The consensus price target hints at a 103.3% upside potential for Green Thumb Industries Inc. (GTBIF). While empirical research shows that this sought-after metric is hardly effective, an upward trend in earnings estimate revisions could mean that the stock will witness an upside in the near term.

Cannabis Stock VRNO Rises 10% in a Month: Time to Buy, Hold or Sell?

Verano's rally follows strong Q2 results, but margin pressure and wider 2026 losses keep the stock in wait-and-watch mode.

Can Green Thumb Industries Inc. (GTBIF) Run Higher on Rising Earnings Estimates?

Green Thumb Industries Inc. (GTBIF) shares have started gaining and might continue moving higher in the near term, as indicated by solid earnings estimate revisions.

Wall Street Analysts Think Green Thumb Industries Inc. (GTBIF) Could Surge 104.86%: Read This Before Placing a Bet

The mean of analysts' price targets for Green Thumb Industries Inc. (GTBIF) points to a 104.9% upside in the stock. While this highly sought-after metric has not proven reasonably effective, strong agreement among analysts in raising earnings estimates does indicate an upside in the stock.

Should You Buy, Hold or Sell GTBIF Stock Post Q2 Earnings Release?

Green Thumb tops Q2 earnings and sales estimates, but can regulatory catalysts, buybacks and expansion plans outweigh pricing pressure and fierce competition?

Should You Buy, Hold or Sell SNDL Stock Post Q4 Earnings Release?

SNDL sinks after weak Q2 2026 earnings, but can cost cuts and U.S. expansion through Parallel offset ongoing cannabis and liquor headwinds?

Is JAZZ Still the Best Cannabis Stock After Federal Rescheduling?

Jazz Pharmaceuticals pairs its FDA-approved CBD blockbuster with a diversified drug portfolio, offering medical cannabis exposure despite ongoing pipeline risks.

GTBIF Stock Climbs 17.5% in Three Months: Time to Invest or Cash Out?

Green Thumb has surged 17.5% in three months as regulatory progress, Q1 growth and buybacks lift sentiment, but competition and pricing pressure persist.

Cannabis Operator Cresco Down 28.5% YTD: How to Play the Stock?

CRLBF is down 28.5% YTD as revenue pressure and competition persist, but retail expansion and improving estimates could shape its next move.

MSOS Hits 2026 High: Which Cannabis Stock Could Light Up Portfolios Ahead Of DEA Hearing?

Equity

The cannabis ETF has surged 104% over the past year, outperforming both the North American Marijuana Index and the S&P 500.

Green Thumb Industries, Inc. engages in the manufacture and distribution of branded cannabis products. Its brands include RYTHM, Dogwalkers, Beboe, Good Green, Doctor Solomon’s, and &Shine. It operates through the Retail and Consumer Packaged Goods segments. The Retail segment focuses on retailing cannabis to patients and consumers. The Consumer Packaged Goods segment refers to the cultivation, production, and sale of cannabis products to retail stores. The company was founded by Benjamin Kovler and Max Cohen on February 18, 2002 and is headquartered in Chicago, IL.

Current Price	$7.70
Prev Close	$8.09
Open	$8.09
Dividend Yield	0.00%
50-Day Moving Average	$7.33
Beta	0.74
Avg. Volume	431,450.71
PE Ratio	14.18

52-Week High	$10.43
52-Week Low	$5.29
Market Capitalization	$1.68B
EPS (Annual)	$0.4819
Price to Book	0.91
Revenue Per Employee	$235,059.00

Feed

News

Sentiment

Earnings

Fundamentals

Info

GTBIF Fundamentals